换一批
换一批Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
作者：
Geoffrey D E,Cuvelier [1]
;
Michelle,Schoettler [2]
;
Nataliya P,Buxbaum [3]
;
Iago,Pinal-Fernandez [4]
;
Marc,Schmalzing [5]
;
Jörg H W,Distler [6]
;
Olaf,Penack [7]
;
Bianca D,Santomasso [8]
;
Robert,Zeiser [9]
;
Klemens,Angstwurm [10]
;
Kelli P A,MacDonald [11]
;
W Taylor,Kimberly [12]
;
Naomi,Taylor [13]
;
Ervina,Bilic [14]
;
Bernhard,Banas [15]
;
Maike,Buettner-Herold [16]
;
Namita,Sinha [17]
;
Hildegard T,Greinix [18]
;
Joseph,Pidala [19]
;
Kirk R,Schultz [20]
;
Kirsten M,Williams [21]
;
Yoshihiro,Inamoto [22]
;
Corey,Cutler [23]
;
Linda M,Griffith [24]
;
Stephanie J,Lee [25]
;
Stefanie,Sarantopoulos [26]
;
Steven Z,Pavletic [27]
;
Daniel,Wolff [28]
作者单位：
Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: gcuvelier@cancercare.mb.ca.
[1]
Children's Healthcare of Atlanta/Aflac Cancer Center, Atlanta, Georgia, United States; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States.
[2]
Department of Pediatrics, Roswell Park Comprehensive Care Center, Buffalo, New York, United States.
[3]
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Baltimore, Maryland, United States; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
[4]
Rheumatology/Clinical Immunology, Department of Internal Medicine II, University of Wuerzburg, Wuerzburg, Germany.
[5]
Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.
[6]
Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
[7]
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
[8]
Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany.
[9]
Department of Neurology, University Medical Center Regensburg, Regensburg, Germany.
[10]
Antigen Presentation and Immunoregulation Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
[11]
Division of Neurocritical Care, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States.
[12]
Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States; Institut de Génétique Moléculaire Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France.
[13]
Department of Neurology, Clinical Hospital Centre Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia.
[14]
Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.
[15]
Department of Nephropathology, Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg (FAU) and University Hospital, Erlangen, Germany.
[16]
Department of Pathology, Health Sciences Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
[17]
Clinical Division of Hematology, Medical University of Graz, Graz, Austria.
[18]
Department of Blood and Marrow Transplantation and Cellular Immunotherapy. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States.
[19]
Pediatric Hematology/Oncology/BMT, BC Children's Hospital, Vancouver, British Columbia, Canada.
[20]
Children's Healthcare of Atlanta/Aflac Cancer Center, Atlanta, Georgia, United States.
[21]
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
[22]
Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, United States.
[23]
Division of Allergy Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States. Electronic address: lgriffith@niaid.nih.gov.
[24]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington, United States.
[25]
Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Department of Immunology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, United States.
[26]
Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States.
[27]
Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
[28]
主题词
慢性病(Chronic Disease);多数赞同(Consensus);移植物抗宿主病(Graft vs Host Disease);人类(Humans);国立卫生研究院(美国)(National Institutes of Health (U.S.));前瞻性研究(Prospective Studies);美国(United States)
DOI
10.1016/j.jtct.2022.05.038
PMID
35662591
发布时间
2023-08-02
- 浏览0
Transplantation and cellular therapy
Transplantation and cellular therapy
2022年28卷8期
426-445页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
